ºù«ÍÞÊÓƵ

Sixteen teams of University of Colorado faculty, researchers and graduate student innovators competed for a combined $1.5 million in startup funding grants.

Camila Uzcategui's venture into 3D printing resulted from a desire to contribute to global healthcare significantly. Through her experiences in NGOs and nonprofits, she identified a glaring need for essential medical devices in health clinics, sowing the seeds for her exploration into additive manufacturing.

College of Arts and Sciences—CU ºù«ÍÞÊÓƵ researcher Karolin Luger, a distinguished professor of biochemistry and Jennie Smoly Caruthers Endowed Chair of Biochemistry, has been awarded the 2023 World Laureates Association Prize in Life Science or Medicine.

The Embark Deep Tech Startup Creator at Venture Partners at CU ºù«ÍÞÊÓƵ has officially launched its first Embark Entrepreneurs in Residence cohort. Embark aims to connect business minds outside the university with breakthrough inventions emerging from CU ºù«ÍÞÊÓƵ's research labs to bring them to market and unleash the full impact of CU ºù«ÍÞÊÓƵ's research into the world.

College of Engineering and Applied Science—Srubar's lab conducts major research into biomimetic and living materials that have the potential to drastically reduce environmental pollution caused by construction activities around the globe.

College of Engineering and Applied Science—Svenja Knappe and her colleagues have developed a helmet that contains 128 sensors and is customizable for different sizes of the human head. Knappe founded the ºù«ÍÞÊÓƵ-based company FieldLine and has begun to bring these sensors to market. In the not-so-distant future, they could aid in the diagnosis and treatment of a wide range of neurological conditions like epilepsy, autism and traumatic brain injuries.

CU ºù«ÍÞÊÓƵ Today—Chemists at CU ºù«ÍÞÊÓƵ have developed a new way to recycle a common type of plastic found in soda bottles and other packaging and are working with Venture Partners at CU ºù«ÍÞÊÓƵ to bring it to real-world applications. The team’s method relies on electricity and some nifty chemical reactions, and it’s simple enough that you can watch the plastic break apart in front of your eyes.

CU ºù«ÍÞÊÓƵ Today—In 2016, Pfizer began collaborating with Sabrina Spencer, a global leader in time-lapse cell imaging and member of the CU Cancer Center, to study how cancer cells respond to their potent new drugs called CDK2 inhibitors.

CU ºù«ÍÞÊÓƵ researcher Linda Watkins and CU startups Beryl Therapeutics Inc., Modendo Inc. and TissueForm Inc. are among 37 companies and researchers awarded Proof of Concept and Early-Stage Capital Retention grants through the Colorado Office of Economic Development and International Trade (OEDIT).

CU ºù«ÍÞÊÓƵ researchers have identified a surprising new player in ALS (amyotrophic lateral sclerosis)—an ancient, virus-like protein. With funding from the ALS Association, the National Institutes of Health, and Venture Partners at CU ºù«ÍÞÊÓƵ, Alexandra Whiteley's lab is now working to understand the molecular pathways involved and to find a way of inhibiting the rogue protein.